ICD-10 Coding for Plasma Cell Tumor(C90.0, C90.00, C90.00B)
Explore detailed ICD-10 coding guidelines for plasma cell tumors, including multiple myeloma, extramedullary plasmacytoma, and solitary plasmacytoma of bone.
Complete code families applicable to Plasma Cell Tumor
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C90.00 | Multiple myeloma not having achieved remission | Use when multiple myeloma is active and not in remission. |
|
| C90.2 | Extramedullary plasmacytoma | Use for extramedullary plasmacytoma without systemic myeloma. |
|
| C90.3 | Solitary plasmacytoma of bone | Use for solitary plasmacytoma of bone without systemic involvement. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPlasma Cell Tumor
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Plasma Cell Tumor.
Missing remission status in coding.
Impact
Clinical: Affects treatment planning and monitoring., Regulatory: Non-compliance with coding standards., Financial: Potential for incorrect reimbursement.
Mitigation
Always append the 7th character for remission status.
Coding C90.0 for asymptomatic plasmacytoma
Impact
Reimbursement: Incorrect coding may lead to reduced reimbursement., Compliance: May result in non-compliance with coding guidelines., Data Quality: Affects accuracy of patient records.
Mitigation
Use C90.2 or C90.3 unless myeloma criteria are met.
Incorrect coding of remission status
Impact
Failure to document remission status accurately can lead to audit flags.
Mitigation
Implement regular training on remission coding and documentation.